HK_L61

AAPL - Daily / Apple Joins the Death Cross Cult of FANGs

NASDAQ:AAPL   Apple Inc
Apple's Impulse Weakening Impulse Structure has finally broken.

We warned of this on February 6th, the Retracement was concluding
as many of the FANGs were seeing 55/199 Crosses occurring.

2C was a weak retracement, we were looking forward to more, but
it simply was not to be.

Yields crossing 1.691 were our LIS for the cross over 2% and onto 2.06
to and through 2.082 / 2.12 / 2.189 / 2.26 / 2.28 and on to the UTL
with a potential Throw over to 2.5%.

Apple will lead 3A (a powerful move lower to new lows) as its weighting
is sizeable for NQ.

As previously indicated 141s are the Initial Price Objective for 3/5 IT.

We believe it can move lower to the 411 EMA @ ~ 133.4.0.

Apple has lost the Edge in innovation and is unable to complete with the
Google's innovations and breadth of Carrier Market Integration.

After months of research into Global Access - the Edge Google has over
Apple is immense. The Pixel 6 is functionally a very basic, well made
Smartphone.

Where it excels is in AI Integration and Carrier switching.

I have begun converting to Google's Hardware and Service for all lines and
services, consolidating a number of Business Lines for Global use while
traveling outside the United States.

Apple is unable to offer anything remotely competitive, their claims to
developing a true Global Phone with improved carrier switching is quite
distant at this point in time.

Margin compression, Debt, a very Real Lack of Innovation (Share Buybacks
as opposed to CapEx Investment), and Accountants gaming the Future... Unlikely
Apple will ever return to its former Halcyon days as a leading TECH Innovator.

______________________________________________________________________


Instead, APPLE will be the Anchor that drags the NQ to new Lows in 3/5 IT and
then 5/5 for the IT Correction.

5/5 will then take this Overhyped Cult to new ATHs into Q3 of 2022.

From there our price Target remains $35 into 2025.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.